Histogen Inc.
HSTO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $4 | $1 | $2 | $11 |
| % Growth | 310.1% | -55.4% | -82% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $2 |
| Gross Profit | $4 | $1 | $1 | $9 |
| % Margin | 100% | 76.1% | 53% | 79.4% |
| R&D Expenses | $5 | $8 | $6 | $4 |
| G&A Expenses | $9 | $8 | $7 | $6 |
| SG&A Expenses | $9 | $8 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | -$0 |
| Operating Expenses | $14 | $16 | $20 | $10 |
| Operating Income | -$11 | -$15 | -$12 | -$12 |
| % Margin | -282.4% | -1,681.9% | -568.9% | -104.8% |
| Other Income/Exp. Net | -$0 | $0 | -$7 | -$2 |
| Pre-Tax Income | -$11 | -$15 | -$19 | -$11 |
| Tax Expense | $0 | $0 | $0 | $2 |
| Net Income | -$11 | -$15 | -$19 | -$11 |
| % Margin | -281.8% | -1,626.8% | -911.6% | -99.4% |
| EPS | -3.46 | -7.51 | -41.6 | -5.02 |
| % Growth | 53.9% | 81.9% | -728.7% | – |
| EPS Diluted | -3.46 | -7.51 | -41.6 | -5.02 |
| Weighted Avg Shares Out | 3 | 2 | 0 | 1 |
| Weighted Avg Shares Out Dil | 3 | 2 | 0 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$15 | -$19 | -$3 |
| % Margin | -278.7% | -1,621.5% | -906% | -24.9% |